Four Researchers Garner Annual GM Foundation Prizes

Late last month, the Detroit-based General Motors Cancer Research Foundation recognized four scientists for their investigations in the fight against cancer with its three annual awards. The cash amount of the three prizes totaled $300,000. AWARDEES: From left, Joseph F. Fraumeni, Edward E. Hartlow, Jr., GM foundation president Joseph G. Fortner, Freerick P. Li. and Norbert Brock. The Charles F. Kettering medal for outstanding contributions to the treatment of cancer was awarded to Norbert

Written byKaren Young Kreeger
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Late last month, the Detroit-based General Motors Cancer Research Foundation recognized four scientists for their investigations in the fight against cancer with its three annual awards. The cash amount of the three prizes totaled $300,000.

awardees AWARDEES: From left, Joseph F. Fraumeni, Edward E. Hartlow, Jr., GM foundation president Joseph G. Fortner, Freerick P. Li. and Norbert Brock.

The Charles F. Kettering medal for outstanding contributions to the treatment of cancer was awarded to Norbert Brock, 83, former chief of the department of cancer research at ASTA-Werke, a pharmaceutical company in Bielefeld, Germany. The Charles S. Mott medal for outstanding research in cancer causation and prevention was shared by Frederick P. Li, 55, chief of the division of cancer epidemiology and control at Dana-Farber Cancer Institute in Boston, and Joseph F. Fraumeni, Jr., 62, director of the epidemiology and biostatistics program at the National Cancer Institute. The Alfred P. Sloan, Jr. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies